Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

CHLAMYDIA - ANVISA Registration 10338930329

Access comprehensive regulatory information for CHLAMYDIA in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10338930329 and manufactured by manufacturer not specified. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until Apr 28, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG, VIRCELL S.L., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10338930329
2 Related Devices
Registration Details
ANVISA Registration Number: 10338930329
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Anti-Chlamydia trachomatis MIF 1 (IgM)
Risk Class IV

Registration Details

10338930329

25351457793202461

93741726000166

Company Information

Dates and Status

Apr 28, 2025

28/04/2035

09/18/2025 19:00:01

Anti-Chlamydia trachomatis MIF 1 (IgM)
Risk Class IV

Registration Details

10338930329

25351457793202461

93741726000166

Company Information

Germany
PT: ALEMANHA

Dates and Status

Apr 28, 2025

28/04/2035

09/18/2025 19:00:01